Evidence map›Paper›PMID 38872103›Full record

ArticleBMC bioinformatics2024

CAraCAl: CAMML with the integration of chromatin accessibility.

Courtney Schiebout, H Robert Frost

Abstract read
In one paragraph

Article in BMC bioinformatics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Courtney SchieboutDepartment of Biomedical Data Science, Dartmouth College, Hanover, NH, 03766, USA. courtney.taylor.schiebout@dartmouth.edu.
H Robert FrostDepartment of Biomedical Data Science, Dartmouth College, Hanover, NH, 03766, USA.

Funding

Translational Engineering in Cancer (TEC)P30CA023108 · NCI · DARTMOUTH COLLEGE · PI Fred W Kolling IV · 1985 to 2026
$91.3M
Zhao - Proj 2P20GM130454 · NIGMS · DARTMOUTH COLLEGE · PI MICHAEL L WHITFIELD · 2019 to 2026
$27.2M
Gene set analysis of single cell genomicsR35GM146586 · NIGMS · DARTMOUTH COLLEGE · PI Hildreth Frost · 2022 to 2026
$2.0M
Cancer-specific gene set testingR21CA253408 · NCI · DARTMOUTH COLLEGE · PI FROST, HILDRETH · 2020 to 2020
$451k
NCI NIH HHS P30 CA023108NCI NIH HHS R21 CA253408NIGMS NIH HHS P20 GM130454NIGMS NIH HHS R35 GM146586NIH HHS P20GM130454NIH HHS P30CA023108NIH HHS R21CA253408NIH HHS R35GM146586
6 · The paper itself

Abstract

backgroundA vital step in analyzing single-cell data is ascertaining which cell types are present in a dataset, and at what abundance. In many diseases, the proportions of varying cell types can have important implications for health and prognosis. Most approaches for cell type annotation have centered around cell typing for single-cell RNA-sequencing (scRNA-seq) and have had promising success. However, reliable methods are lacking for many other single-cell modalities such as single-cell sequencing assay for transposase-accessible chromatin (scATAC-seq), which quantifies the extent to which genes of interest in each cell are epigenetically "open" for expression.

resultsTo leverage the informative potential of scATAC-seq data, we developed CAMML with the integration of chromatin accessibility (CAraCAl), a bioinformatic method that performs cell typing on scATAC-seq data. CAraCAl performs cell typing by scoring each cell for its enrichment of cell type-specific gene sets. These gene sets are composed of the most upregulated or downregulated genes present in each cell type according to projected gene activity.

conclusionsWe found that CAraCAl does not improve performance beyond CAMML when scRNA-seq is present, but if only scATAC-seq is available, CAraCAl performs cell typing relatively successfully. As such, we also discuss best practices for cell typing and the strengths and weaknesses of various cell annotation options.

Indexed as

ChromatinComputational BiologyHumansSequence Analysis, RNASingle-Cell AnalysisSoftwareTransposasesChromatinTransposasesCell typingGene activityscATAC-seqscRNA-seq

Identifiers

PMID38872103
PMCPMC11170880

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.